MAPK-driven epithelial cell plasticity drives colorectal cancer therapeutic resistance
Mark White, Megan L. Mills, Laura M. Millett, Kathryn Gilroy et autres
31 citationsNature
Janet Graham
Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.
72Publications signalées
10849Citations signalées
2Affiliations récentes
Institutions déclarées
Domaines associés
Colorectal Cancer Treatments and StudiesColorectal Cancer Surgical TreatmentsGastric Cancer Management and OutcomesGenetic factors in colorectal cancerColorectal and Anal Carcinomas
Publications récentes
Stereotactic Body Radiation Therapy vs. Palliative Radiotherapy, with or without Immunotherapy, in Metastatic Bladder Cancer: A Canadian Population Analysis
Erick Gutiérrez, Janet Graham, Rodney H. Breau, P. Black et autres
0 citationsInternational Journal of Radiation Oncology*Biology*Physics
Emergency and non-emergency routes to cancer diagnoses in 2020 and 2021: A Population-based study of 154,863 patients
C. Purdie, Gavin Clark, David Cameron, Russell Petty et autres
0 citationsJournal of Cancer Policy
598TiP PRODIGE 86 (FFCD 2103 - GONO) – FOLFIRINOX SBA: Phase II randomized trial to evaluate mFOLFIRINOX and mFOLFOX in the treatment of locally advanced or metastatic small bowel adenocarcinoma
Thomas Aparicio, Anthony Turpin, Aziz Zaanan, Arnaud de la Fouchardière et autres
0 citationsAnnals of Oncology
NEOPRISM-CRC: Neoadjuvant pembrolizumab stratified to tumour mutation burden for high risk stage 2 or stage 3 deficient-MMR/MSI-high colorectal cancer.
Kai‐Keen Shiu, Yanrong Jiang, Mark Saunders, Jenny F. Seligmann et autres
37 citationsJournal of Clinical Oncology
Results from a randomised, open-label trial of a multimodal intervention (exercise, nutrition and anti-inflammatory medication) plus standard care versus standard care alone to attenuate cachexia in patients with advanced cancer undergoing chemotherapy.
Tora S. Solheim, Barry Laird, Trude R. Balstad, Guro B. Stene et autres
19 citationsJournal of Clinical Oncology
JAK/STAT3 represents a therapeutic target for colorectal cancer patients with stromal-rich tumors
Kathryn A.F. Pennel, Phimmada Hatthakarnkul, Colin S. Wood, Guang‐Yu Lian et autres
46 citationsJournal of Experimental & Clinical Cancer Research
Correction to: Evolution of surgical approach to rectal cancer resection: A multinational registry assessment
Julie Sijmons, Jan Willem T. Dekker, Jurriaan B. Tuynman, Helen Mohan et autres
0 citationsInternational Journal of Colorectal Disease
PRIMUS-002: A multicentre, open-label, phase II study examining FOLFOX and nab-paclitaxel (FA) and nab-paclitaxel and gemcitabine (AG) as neoadjuvant therapy for (borderline) resectable pancreatic cancer (PC), focusing on biomarker and liquid biopsy development.
Derek Grose, Nigel B. Jamieson, Ganesh Radhakrishna, M. Hawkins et autres
4 citationsJournal of Clinical Oncology
Evolution of surgical approach to rectal cancer resection: A multinational registry assessment
Julie Sijmons, Jan Willem T. Dekker, Jurriaan B. Tuynman, Helen Mohan et autres
3 citationsInternational Journal of Colorectal Disease
Abstract B048: NUC-3373 in combination with irinotecan (NUFIRI) or oxaliplatin (NUFOX) and bevacizumab for second-line treatment of patients with advanced colorectal cancer (NuTide:302)
Khurum Khan, Uma Mukherjee, Benjamin L. Schlechter, Kristen K. Ciombor et autres
1 citationMolecular Cancer Therapeutics
Abstract B049: Phase II study of NUC-3373, leucovorin, irinotecan (NUFIRI) + bevacizumab vs FOLFIRI + bevacizumab for the second-line treatment of patients with advanced/metastatic colorectal cancer (NuTide:323)
Richard H. Wilson, Kristen K. Ciombor, Andrew L. Coveler, Janet Graham et autres
0 citationsMolecular Cancer Therapeutics
BNTIC News n’est pas le producteur de ces données. Recherche à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, ROR et la Banque mondiale, sans clé ; OpenAlex reste optionnel. Aucun service payant requis, aucune donnée externe enregistrée en base. Sources et limites.